Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Merighi

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Chemmedchem|March 26, 2018
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 LigandsGiulio Ragusa, Serena Bencivenni, Paula Morales, et al.
Bioorganic Chemistry|July 22, 2020
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanesGabriele Murineddu, Battistina Asproni, Paola Corona, et al.
Molecules (Basel, Switzerland)|September 28, 2021
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane DerivativesSandra Piras, Gabriele Murineddu, Giovanni Loriga, et al.
Molecular Pharmacology|March 25, 2005
Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20Stefania Gessi, Katia Varani, Stefania Merighi, et al.
Journal of Medicinal Chemistry|March 5, 2004
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
International Journal of Molecular Sciences|February 26, 2025
Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor ActivityPaola Corona, Stefania Gessi, Roberta Ibba, et al.
Molecules (Basel, Switzerland)|May 14, 2022
Pathophysiological Role and Medicinal Chemistry of A<sub>2A</sub> Adenosine Receptor Antagonists in Alzheimer's DiseaseStefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Biochemical Pharmacology|October 13, 2005
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptorsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
Medicinal Research Reviews|July 7, 2017
A<sub>3</sub> Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to TherapyKenneth A Jacobson, Stefania Merighi, Katia Varani, et al.
Journal of Medicinal Chemistry|February 21, 2003
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptorPier Giovanni Baraldi, Romeo Romagnoli, Maria Giovanna Pavani, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Chemmedchem|March 26, 2018
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 LigandsGiulio Ragusa, Serena Bencivenni, Paula Morales, et al.
Bioorganic Chemistry|July 22, 2020
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanesGabriele Murineddu, Battistina Asproni, Paola Corona, et al.
Molecules (Basel, Switzerland)|September 28, 2021
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane DerivativesSandra Piras, Gabriele Murineddu, Giovanni Loriga, et al.
Molecular Pharmacology|March 25, 2005
Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20Stefania Gessi, Katia Varani, Stefania Merighi, et al.
Journal of Medicinal Chemistry|March 5, 2004
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Delia Preti, et al.
International Journal of Molecular Sciences|February 26, 2025
Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor ActivityPaola Corona, Stefania Gessi, Roberta Ibba, et al.
Molecules (Basel, Switzerland)|May 14, 2022
Pathophysiological Role and Medicinal Chemistry of A<sub>2A</sub> Adenosine Receptor Antagonists in Alzheimer's DiseaseStefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Biochemical Pharmacology|October 13, 2005
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptorsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
Medicinal Research Reviews|July 7, 2017
A<sub>3</sub> Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to TherapyKenneth A Jacobson, Stefania Merighi, Katia Varani, et al.
Journal of Medicinal Chemistry|February 21, 2003
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptorPier Giovanni Baraldi, Romeo Romagnoli, Maria Giovanna Pavani, et al.
Pageof 11